CHRONIC GRANULOMATOUS DISEASE AND THE NTTROBLUE TETRAZOLIUM (NBT) TEST CRITICAL REVIEW-JUNE 1988
暂无分享,去创建一个
[1] S. Douglas,et al. Phorbol Myristate Acetate Induced Oxidation of 2′,7′‐Dichlorofluorescin by Neutrophils From Patients With Chronic Granulomatous Disease , 1988, Journal of leukocyte biology.
[2] M. V. van Schaik,et al. Detection of carriers of the autosomal form of chronic granulomatous disease. , 1988, Blood.
[3] B. Babior,et al. Chronic granulomatous disease. , 1990, Advances in human genetics.
[4] A. Durandy,et al. Prenatal diagnosis of chronic granulomatous disease (CGD) in four high risk male fetuses , 1987, Prenatal diagnosis.
[5] K. Nicolaides,et al. ANTENATAL DIAGNOSIS OF CHRONIC GRANULOMATOUS DISEASE , 1986, The Lancet.
[6] S. Taniuchi,et al. A quantitative assay of oxidative metabolism by neutrophils in whole blood using flow cytometry. , 1985, Journal of immunological methods.
[7] D. Wara,et al. Prenatal diagnosis of chronic granulomatous disease. , 1984, American journal of medical genetics.
[8] R. Seger,et al. PRENATAL DIAGNOSIS OF CHRONIC GRANULOMATOUS DISEASE: UNRELIABILITY OF FIBROBLAST NITROBLUE TETRAZOLIUM TEST , 1981, The Lancet.
[9] P. Newburger,et al. Prenatal diagnosis of chronic granulomatous disease. , 1979, The New England journal of medicine.
[10] A. Nakagawara,et al. Identification of a carrier mother of a female patient with chronic granulomatous disease. , 1976, The Journal of pediatrics.
[11] C. Watanakunakorn,et al. An appraisal of the nitroblue tetrazolium reduction test. , 1975, The American journal of medicine.
[12] D. Nathan,et al. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. , 1968, The New England journal of medicine.